Form 4: OptimizeRx Officer Converts RSUs, Covers Taxes
Insider Transaction Report
OptimizeRx's Chief Legal & Admin Officer, Marion Odence-Ford, converted restricted stock units into common stock and subsequently sold a portion to cover tax obligations.
Summary
- Marion Odence-Ford, Chief Legal & Admin Officer of OptimizeRx Corp (OPRX), reported a transaction on October 3, 2025.
- Acquired 6,649 shares of common stock through the conversion of restricted stock units (RSUs).
- Disposed of 1,952 shares of common stock at a price of $18.75 per share to satisfy tax withholding obligations.
- Following these transactions, Odence-Ford beneficially owns 90,598 shares of OptimizeRx common stock.
- The restricted stock units vest in three equal annual installments, with the first installment beginning October 3, 2023.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction involving the vesting of restricted stock units and subsequent sale of shares for tax withholding, which is a neutral event with no significant positive or negative implications for the company's operations or financial health.
Positives
- The conversion of restricted stock units indicates the vesting of previously granted equity compensation, reflecting continued employment and performance.
- The transaction is a standard part of executive compensation plans, demonstrating the company's commitment to aligning management incentives with shareholder interests.
Negatives
- A portion of shares (1,952) was sold, reducing direct beneficial ownership, although this was specifically for tax withholding purposes and not a discretionary sale.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Minimal direct impact as it's a routine compensation event. The sale for tax purposes is not a discretionary sale indicating a change in sentiment.
- Employees: Reflects standard equity compensation practices for executives.
Next Steps
- Future vesting of remaining restricted stock units in equal annual installments.
Key Dates
| Date | Description |
|---|---|
| 10/03/2023 | First anniversary of RSU grant date, marking the beginning of three equal annual vesting installments. |
| 10/03/2025 | Date of RSU conversion to common stock and subsequent tax withholding transaction. |
| 10/07/2025 | Date the Form 4 was signed by Marion K. Odence-Ford. |
Keywords
OptimizeRx, OPRX, Form 4, Insider Transaction, Restricted Stock Units, RSU Conversion, Tax Withholding, Marion Odence-Ford, Chief Legal & Admin Officer, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.